Earnings · China A-shares
Xizang Weixinkang Pharmaceutical Co., Ltd. Class A (603676) earnings
Xizang Weixinkang Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-29: net profit -19.45% year on year, -19.16% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -0.72% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- -19.45%
- Excl. one-offs YoY
- -19.16%
- Net profit QoQ
- -54.92%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +0.00% | — |
| 3 days | -0.72% | — |
| 7 days | -1.55% | — |
| 14 days | -5.97% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 1 of 6 reports (average -2.64%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | ¥176.55M | -19.45% | -19.16% | -5.31% | 0.41 | 11.54% | -0.72% | — | — |
| 2026 interim report | 2026-08-28 | ¥142.93M | -21.81% | -24.42% | -0.32% | 0.33 | 9.31% | -0.85% | -6.30% | +3.39% |
| 2026 Q1 report | 2026-04-24 | ¥68.34M | -19.16% | -8.61% | +8.90% | 0.16 | 4.52% | +4.22% | -13.24% | -13.65% |
| 2025 annual report | 2026-04-24 | ¥232.85M | -5.41% | -4.62% | -12.65% | 0.54 | 16.05% | +4.22% | -13.24% | -13.65% |
| 2025 Q3 report | 2025-10-30 | ¥219.18M | -9.90% | -14.01% | -13.27% | 0.51 | 15.01% | -4.33% | -6.79% | -2.04% |
| 2025 interim report | 2025-08-28 | ¥182.79M | +11.82% | +17.86% | -7.43% | 0.42 | 12.49% | -4.05% | -9.63% | -15.13% |
| 2025 Q1 report | 2025-04-26 | ¥84.54M | -10.93% | +31.10% | -6.93% | 0.20 | 5.92% | -10.08% | -1.67% | -4.91% |
| 2024 annual report | 2025-04-26 | ¥246.17M | +15.02% | +22.86% | -1.69% | 0.57 | 17.86% | -10.08% | -1.67% | -4.91% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.